脱细胞化梅罗白粉作为一种潜在的环保静血材料,用于治疗非可压缩隐性出血
Jiawen Wang1, Jinfu Wang2, Han Li2
1Department of Urology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, China.
Biomaterials advances
|October 30, 2025
概括
这项研究引入了脱细胞化波梅罗白色粉末 (DPP) 作为一种用于隐性出血的新型血静剂. 通过促进血液凝结,DPP有效控制内出血,提供一个环保和负担得起的解决方案.
科学领域:
- 生物材料科学 生物材料科学
- 血液静止和血栓形成
- 再生医学是一种再生医学.
背景情况:
- 隐性出血,通常是内部和未检测到的,带来了重大的健康风险,包括贫血和死亡率.
- 现有的静血材料主要针对外部出血,在管理内部出血方面留下了一个空白.
- 需要具有成本效益,生物相容性和环保的静血剂至关重要.
研究的目的:
- 为了研究富含纤维素的pomelo albedo粉末作为环保的静血剂的潜力.
- 为了评估脱细胞化波梅洛阿尔贝多粉 (DPP) 在控制隐性出血方面的疗效.
- 探索DPP促进血液静止的机制.
主要方法:
- 波梅洛白色被脱细胞化以创建一个多孔的结构,然后冷磨成粉末 (DPP) 的不同颗粒大小.
- 在DPP进行了体外生物相容性评估.
- 在体外进行了血液吸收和凝血因子度测试.
- 在体内研究中使用了肝损伤,大腿静脉损伤和尾巴截肢的模型来评估DPP的静血性能.
主要成果:
- 脱细胞化波梅罗白色粉末 (DPP) 在不同颗粒大小中表现出极好的生物相容性.
- DPP迅速吸收血液,集中凝血因子,并促进血小板聚合和血栓生成.
- 在多重伤害模型中,DPP显著降低了出血量,并抑制了隐性出血.
- DPP200治疗组显示出明显改善的静血结局.
结论:
- 脱细胞化波梅罗白色粉 (DPP) 是一个有前途的,廉价的,环保的静血材料.
- DPP提供了一种新且有效的策略来管理隐性出血.
- 这些发现支持DPP作为传统静血剂的可行替代品.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...


